Annual report

Period2024-12-01 → 2025-11-30
Filed2026-02-25
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 151
MetricValuePeriodScopeSource row
Revenue¥62.7bn2024-12-01 → 2025-11-30Cons.Net sales
Revenue¥58.0bn2023-12-01 → 2024-11-30Cons.Net sales
Revenue¥52.0bn2022-12-01 → 2023-11-30vCons.Net sales (5-year summary)
Revenue¥49.6bn2021-12-01 → 2022-11-30vCons.Net sales (5-year summary)
Revenue¥72.3bn2020-12-01 → 2021-11-30dCons.Net sales (5-year summary)
Operating income¥3.0bn2024-12-01 → 2025-11-30Cons.Operating income
Operating income¥2.8bn2023-12-01 → 2024-11-30Cons.Operating income
Ordinary income¥2.9bn2024-12-01 → 2025-11-30Cons.Ordinary income
Ordinary income¥2.8bn2023-12-01 → 2024-11-30Cons.Ordinary income
Ordinary income¥1.4bn2022-12-01 → 2023-11-30vCons.Ordinary income loss (5-year summary)
Ordinary income¥887m2021-12-01 → 2022-11-30vCons.Ordinary income loss (5-year summary)
Ordinary income¥2.4bn2020-12-01 → 2021-11-30dCons.Ordinary income loss (5-year summary)
Profit before tax¥2.9bn2024-12-01 → 2025-11-30Cons.Income before income taxes
Profit before tax−¥1.5bn2023-12-01 → 2024-11-30Cons.Income before income taxes
Net income (owners)¥2.2bn2024-12-01 → 2025-11-30Cons.Profit loss attributable to owners of parent
Net income (owners)−¥2.5bn2023-12-01 → 2024-11-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥1.2bn2022-12-01 → 2023-11-30vCons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥579m2021-12-01 → 2022-11-30vCons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥1.7bn2020-12-01 → 2021-11-30dCons.Profit loss attributable to owners of parent (5-year summary)
Net income¥2.2bn2024-12-01 → 2025-11-30Cons.Profit loss
Net income−¥2.5bn2023-12-01 → 2024-11-30Cons.Profit loss
Total assets¥75.4bnat 2025-11-30Cons.Assets
Total assets¥64.6bnat 2024-11-30Cons.Assets
Total assets¥67.3bnat 2023-11-30vCons.Total assets (5-year summary)
Total assets¥63.6bnat 2022-11-30vCons.Total assets (5-year summary)
Total assets¥63.6bnat 2021-11-30dCons.Total assets (5-year summary)
Total liabilities¥48.0bnat 2025-11-30Cons.Liabilities
Total liabilities¥39.3bnat 2024-11-30Cons.Liabilities
Net assets / equity¥27.4bnat 2025-11-30Cons.Net assets
Net assets / equity¥25.3bnat 2024-11-30Cons.Net assets
Net assets / equity¥28.6bnat 2023-11-30vCons.Net assets
Net assets / equity¥27.1bnat 2022-11-30vCons.Net assets (5-year summary)
Net assets / equity¥27.0bnat 2021-11-30dCons.Net assets (5-year summary)
Cash and deposits¥10.2bnat 2025-11-30Cons.Cash and deposits
Cash and deposits¥6.1bnat 2024-11-30Cons.Cash and deposits
Cash & equivalents¥10.1bnat 2025-11-30Cons.Cash and cash equivalents
Cash & equivalents¥6.0bnat 2024-11-30Cons.Cash and cash equivalents
Cash & equivalents¥6.8bnat 2023-11-30vCons.Cash and cash equivalents
Cash & equivalents¥6.8bnat 2022-11-30vCons.Cash and cash equivalents (5-year summary)
Cash & equivalents¥10.8bnat 2021-11-30dCons.Cash and cash equivalents (5-year summary)
Operating cash flow¥3.4bn2024-12-01 → 2025-11-30Cons.Net cash provided by used in operating activities
Operating cash flow¥4.8bn2023-12-01 → 2024-11-30Cons.Net cash provided by used in operating activities
Operating cash flow¥1.6bn2022-12-01 → 2023-11-30vCons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow−¥742m2021-12-01 → 2022-11-30vCons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥1.3bn2020-12-01 → 2021-11-30dCons.Net cash provided by used in operating activities (5-year summary)
Investing cash flow−¥5.6bn2024-12-01 → 2025-11-30Cons.Net cash provided by used in investment activities
Investing cash flow−¥2.9bn2023-12-01 → 2024-11-30Cons.Net cash provided by used in investment activities
Investing cash flow−¥2.8bn2022-12-01 → 2023-11-30vCons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥2.2bn2021-12-01 → 2022-11-30vCons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥4.4bn2020-12-01 → 2021-11-30dCons.Net cash provided by used in investing activities (5-year summary)
Financing cash flow¥6.2bn2024-12-01 → 2025-11-30Cons.Net cash provided by used in financing activities
Financing cash flow−¥2.7bn2023-12-01 → 2024-11-30Cons.Net cash provided by used in financing activities
Financing cash flow¥1.1bn2022-12-01 → 2023-11-30vCons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥1.1bn2021-12-01 → 2022-11-30vCons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow¥6.4bn2020-12-01 → 2021-11-30dCons.Net cash provided by used in financing activities (5-year summary)
EPS (basic)¥54.232024-12-01 → 2025-11-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-63.182023-12-01 → 2024-11-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥29.472022-12-01 → 2023-11-30vCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥14.562021-12-01 → 2022-11-30vCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥46.862020-12-01 → 2021-11-30dCons.Basic earnings loss per share (5-year summary)
EPS (diluted)¥46.632020-12-01 → 2021-11-30dCons.Diluted earnings per share (5-year summary)
Net assets per share¥670.86at 2025-11-30Cons.Net assets per share (5-year summary)
Net assets per share¥625.15at 2024-11-30Cons.Net assets per share (5-year summary)
Net assets per share¥719.53at 2023-11-30vCons.Net assets per share (5-year summary)
Net assets per share¥685.24at 2022-11-30vCons.Net assets per share (5-year summary)
Net assets per share¥677.09at 2021-11-30dCons.Net assets per share (5-year summary)
Equity ratio35.9%at 2025-11-30Cons.Equity to asset ratio (5-year summary)
Equity ratio39.0%at 2024-11-30Cons.Equity to asset ratio (5-year summary)
Equity ratio42.3%at 2023-11-30vCons.Equity to asset ratio (5-year summary)
Equity ratio42.5%at 2022-11-30vCons.Equity to asset ratio (5-year summary)
Equity ratio42.5%at 2021-11-30dCons.Equity to asset ratio (5-year summary)
ROE8.4%2024-12-01 → 2025-11-30Cons.Rate of return on equity (5-year summary)
ROE-9.4%2023-12-01 → 2024-11-30Cons.Rate of return on equity (5-year summary)
ROE4.2%2022-12-01 → 2023-11-30vCons.Rate of return on equity (5-year summary)
ROE2.1%2021-12-01 → 2022-11-30vCons.Rate of return on equity (5-year summary)
ROE7.1%2020-12-01 → 2021-11-30dCons.Rate of return on equity (5-year summary)
Employees1,543at 2025-11-30Cons.Number of employees
Employees1,420at 2024-11-30Cons.Number of employees
Employees1,404at 2023-11-30vCons.Number of employees
Employees1,383at 2022-11-30vCons.Number of employees
Employees1,368at 2021-11-30dCons.Number of employees
Revenue¥3.8bn2024-12-01 → 2025-11-30StandaloneOperating revenue1
Revenue¥2.9bn2023-12-01 → 2024-11-30StandaloneOperating revenue1
Revenue¥2.8bn2022-12-01 → 2023-11-30vStandaloneOperating revenue1 (5-year summary)
Revenue¥2.8bn2021-12-01 → 2022-11-30vStandaloneOperating revenue1 (5-year summary)
Revenue¥23.0bn2020-12-01 → 2021-11-30dStandaloneNet sales (5-year summary)
Revenue¥1.3bn2020-12-01 → 2021-11-30dStandaloneOperating revenue1 (5-year summary)
Operating income¥693m2024-12-01 → 2025-11-30StandaloneOperating income
Operating income¥84m2023-12-01 → 2024-11-30StandaloneOperating income
Ordinary income¥181m2024-12-01 → 2025-11-30StandaloneOrdinary income
Ordinary income−¥29m2023-12-01 → 2024-11-30StandaloneOrdinary income
Ordinary income¥209m2022-12-01 → 2023-11-30vStandaloneOrdinary income loss (5-year summary)
Ordinary income¥290m2021-12-01 → 2022-11-30vStandaloneOrdinary income loss (5-year summary)
Ordinary income¥304m2020-12-01 → 2021-11-30dStandaloneOrdinary income loss (5-year summary)
Profit before tax¥406m2024-12-01 → 2025-11-30StandaloneIncome before income taxes
Profit before tax¥214m2023-12-01 → 2024-11-30StandaloneIncome before income taxes
Net income¥294m2024-12-01 → 2025-11-30StandaloneProfit loss
Net income¥92m2023-12-01 → 2024-11-30StandaloneProfit loss
Net income¥702m2022-12-01 → 2023-11-30vStandaloneNet income loss (5-year summary)
Net income¥831m2021-12-01 → 2022-11-30vStandaloneNet income loss (5-year summary)
Net income¥788m2020-12-01 → 2021-11-30dStandaloneNet income loss (5-year summary)
Total assets¥37.5bnat 2025-11-30StandaloneAssets
Total assets¥31.0bnat 2024-11-30StandaloneAssets
Total assets¥32.7bnat 2023-11-30vStandaloneTotal assets (5-year summary)
Total assets¥30.1bnat 2022-11-30vStandaloneTotal assets (5-year summary)
Total assets¥30.2bnat 2021-11-30dStandaloneTotal assets (5-year summary)
Total liabilities¥24.1bnat 2025-11-30StandaloneLiabilities
Total liabilities¥17.3bnat 2024-11-30StandaloneLiabilities
Net assets / equity¥13.4bnat 2025-11-30StandaloneNet assets
Net assets / equity¥13.7bnat 2024-11-30StandaloneNet assets
Net assets / equity¥14.6bnat 2023-11-30vStandaloneNet assets
Net assets / equity¥13.9bnat 2022-11-30vStandaloneNet assets (5-year summary)
Net assets / equity¥14.0bnat 2021-11-30dStandaloneNet assets (5-year summary)
Cash and deposits¥2.1bnat 2025-11-30StandaloneCash and deposits
Cash and deposits¥568mat 2024-11-30StandaloneCash and deposits
EPS (basic)¥7.292024-12-01 → 2025-11-30StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥2.322023-12-01 → 2024-11-30StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥17.792022-12-01 → 2023-11-30vStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥20.882021-12-01 → 2022-11-30vStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥21.272020-12-01 → 2021-11-30dStandaloneBasic earnings loss per share (5-year summary)
EPS (diluted)¥21.162020-12-01 → 2021-11-30dStandaloneDiluted earnings per share (5-year summary)
Dividend per share¥182024-12-01 → 2025-11-30StandaloneDividend paid per share (5-year summary)
Dividend per share¥182023-12-01 → 2024-11-30StandaloneDividend paid per share (5-year summary)
Dividend per share¥182022-12-01 → 2023-11-30vStandaloneDividend paid per share (5-year summary)
Dividend per share¥182021-12-01 → 2022-11-30vStandaloneDividend paid per share (5-year summary)
Dividend per share¥182020-12-01 → 2021-11-30dStandaloneDividend paid per share (5-year summary)
Net assets per share¥331.29at 2025-11-30StandaloneNet assets per share (5-year summary)
Net assets per share¥340.64at 2024-11-30StandaloneNet assets per share (5-year summary)
Net assets per share¥370.38at 2023-11-30vStandaloneNet assets per share (5-year summary)
Net assets per share¥352.82at 2022-11-30vStandaloneNet assets per share (5-year summary)
Net assets per share¥350.47at 2021-11-30dStandaloneNet assets per share (5-year summary)
Equity ratio35.7%at 2025-11-30StandaloneEquity to asset ratio (5-year summary)
Equity ratio44.2%at 2024-11-30StandaloneEquity to asset ratio (5-year summary)
Equity ratio44.8%at 2023-11-30vStandaloneEquity to asset ratio (5-year summary)
Equity ratio46.2%at 2022-11-30vStandaloneEquity to asset ratio (5-year summary)
Equity ratio46.3%at 2021-11-30dStandaloneEquity to asset ratio (5-year summary)
ROE2.2%2024-12-01 → 2025-11-30StandaloneRate of return on equity (5-year summary)
ROE0.7%2023-12-01 → 2024-11-30StandaloneRate of return on equity (5-year summary)
ROE4.9%2022-12-01 → 2023-11-30vStandaloneRate of return on equity (5-year summary)
ROE6.0%2021-12-01 → 2022-11-30vStandaloneRate of return on equity (5-year summary)
ROE5.9%2020-12-01 → 2021-11-30dStandaloneRate of return on equity (5-year summary)
Shares issued41,097,566at 2025-11-30StandaloneTotal number of issued shares (5-year summary)
Shares issued40,982,832at 2024-11-30StandaloneTotal number of issued shares (5-year summary)
Shares issued40,884,504at 2023-11-30vStandaloneTotal number of issued shares (5-year summary)
Shares issued40,772,366at 2022-11-30vStandaloneTotal number of issued shares (5-year summary)
Shares issued40,630,087at 2021-11-30dStandaloneTotal number of issued shares (5-year summary)
Employees96at 2025-11-30StandaloneNumber of employees
Employees95at 2024-11-30StandaloneNumber of employees
Employees93at 2023-11-30vStandaloneNumber of employees
Employees105at 2022-11-30vStandaloneNumber of employees
Employees109at 2021-11-30dStandaloneNumber of employees

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 84
SegmentItemPeriodValue
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsdepreciation2024-12-01 → 2025-11-30¥0
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsemployeesat 2025-11-3011 pure
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2024-12-01 → 2025-11-30¥64m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2024-12-01 → 2025-11-30¥57m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2024-12-01 → 2025-11-30¥7m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2024-12-01 → 2025-11-30−¥363m
Reconciling Itemsreconcilingdepreciation2024-12-01 → 2025-11-30¥387m
Reconciling Itemsreconcilingrevenue2024-12-01 → 2025-11-30−¥1.3bn
Reconciling Itemsreconcilingrevenue intersegment2024-12-01 → 2025-11-30−¥1.3bn
Reconciling Itemsreconcilingsegment profit2024-12-01 → 2025-11-30−¥80m
Fine Chemicalsreportable segmentdepreciation2024-12-01 → 2025-11-30¥1.1bn
Fine Chemicalsreportable segmentemployeesat 2025-11-30567 pure
Fine Chemicalsreportable segmentrevenue2024-12-01 → 2025-11-30¥23.3bn
Fine Chemicalsreportable segmentrevenue external2024-12-01 → 2025-11-30¥22.3bn
Fine Chemicalsreportable segmentrevenue intersegment2024-12-01 → 2025-11-30¥924m
Fine Chemicalsreportable segmentsegment profit2024-12-01 → 2025-11-30¥909m
Health And Beauty Care Foodreportable segmentdepreciation2024-12-01 → 2025-11-30¥62m
Health And Beauty Care Foodreportable segmentemployeesat 2025-11-30301 pure
Health And Beauty Care Foodreportable segmentrevenue2024-12-01 → 2025-11-30¥18.3bn
Health And Beauty Care Foodreportable segmentrevenue external2024-12-01 → 2025-11-30¥18.2bn
Health And Beauty Care Foodreportable segmentrevenue intersegment2024-12-01 → 2025-11-30¥76m
Health And Beauty Care Foodreportable segmentsegment profit2024-12-01 → 2025-11-30¥700m
Industrial Chemicalsreportable segmentdepreciation2024-12-01 → 2025-11-30¥325m
Industrial Chemicalsreportable segmentemployeesat 2025-11-30334 pure
Industrial Chemicalsreportable segmentrevenue2024-12-01 → 2025-11-30¥9.7bn
Industrial Chemicalsreportable segmentrevenue external2024-12-01 → 2025-11-30¥9.7bn
Industrial Chemicalsreportable segmentrevenue intersegment2024-12-01 → 2025-11-30¥3m
Industrial Chemicalsreportable segmentsegment profit2024-12-01 → 2025-11-30¥733m
Medicalreportable segmentdepreciation2024-12-01 → 2025-11-30¥260m
Medicalreportable segmentemployeesat 2025-11-30225 pure
Medicalreportable segmentrevenue2024-12-01 → 2025-11-30¥12.8bn
Medicalreportable segmentrevenue external2024-12-01 → 2025-11-30¥12.4bn
Medicalreportable segmentrevenue intersegment2024-12-01 → 2025-11-30¥321m
Medicalreportable segmentsegment profit2024-12-01 → 2025-11-30¥1.1bn
—segment totaldepreciation2024-12-01 → 2025-11-30¥1.7bn
—segment totalemployeesat 2025-11-301427 pure
—segment totalrevenue2024-12-01 → 2025-11-30¥64.0bn
—segment totalrevenue external2024-12-01 → 2025-11-30¥62.7bn
—segment totalrevenue intersegment2024-12-01 → 2025-11-30¥1.3bn
—segment totalsegment profit2024-12-01 → 2025-11-30¥3.5bn
Total Of Reportable Segments And Otherssegment totaldepreciation2024-12-01 → 2025-11-30¥1.7bn
Total Of Reportable Segments And Otherssegment totalrevenue2024-12-01 → 2025-11-30¥64.1bn
Total Of Reportable Segments And Otherssegment totalrevenue external2024-12-01 → 2025-11-30¥62.7bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2024-12-01 → 2025-11-30¥1.3bn
Total Of Reportable Segments And Otherssegment totalsegment profit2024-12-01 → 2025-11-30¥3.1bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsdepreciation2023-12-01 → 2024-11-30¥3m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2023-12-01 → 2024-11-30¥46m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2023-12-01 → 2024-11-30¥38m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2023-12-01 → 2024-11-30¥8m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2023-12-01 → 2024-11-30−¥129m
Reconciling Itemsreconcilingdepreciation2023-12-01 → 2024-11-30¥426m
Reconciling Itemsreconcilingrevenue2023-12-01 → 2024-11-30−¥1.4bn
Reconciling Itemsreconcilingrevenue intersegment2023-12-01 → 2024-11-30−¥1.4bn
Reconciling Itemsreconcilingsegment profit2023-12-01 → 2024-11-30−¥6m
Fine Chemicalsreportable segmentdepreciation2023-12-01 → 2024-11-30¥1.0bn
Fine Chemicalsreportable segmentrevenue2023-12-01 → 2024-11-30¥22.0bn
Fine Chemicalsreportable segmentrevenue external2023-12-01 → 2024-11-30¥21.1bn
Fine Chemicalsreportable segmentrevenue intersegment2023-12-01 → 2024-11-30¥912m
Fine Chemicalsreportable segmentsegment profit2023-12-01 → 2024-11-30¥219m
Health And Beauty Care Foodreportable segmentdepreciation2023-12-01 → 2024-11-30¥48m
Health And Beauty Care Foodreportable segmentrevenue2023-12-01 → 2024-11-30¥15.3bn
Health And Beauty Care Foodreportable segmentrevenue external2023-12-01 → 2024-11-30¥15.2bn
Health And Beauty Care Foodreportable segmentrevenue intersegment2023-12-01 → 2024-11-30¥94m
Health And Beauty Care Foodreportable segmentsegment profit2023-12-01 → 2024-11-30¥623m
Industrial Chemicalsreportable segmentdepreciation2023-12-01 → 2024-11-30¥323m
Industrial Chemicalsreportable segmentrevenue2023-12-01 → 2024-11-30¥10.3bn
Industrial Chemicalsreportable segmentrevenue external2023-12-01 → 2024-11-30¥10.2bn
Industrial Chemicalsreportable segmentrevenue intersegment2023-12-01 → 2024-11-30¥70m
Industrial Chemicalsreportable segmentsegment profit2023-12-01 → 2024-11-30¥807m
Medicalreportable segmentdepreciation2023-12-01 → 2024-11-30¥211m
Medicalreportable segmentrevenue2023-12-01 → 2024-11-30¥11.8bn
Medicalreportable segmentrevenue external2023-12-01 → 2024-11-30¥11.5bn
Medicalreportable segmentrevenue intersegment2023-12-01 → 2024-11-30¥315m
Medicalreportable segmentsegment profit2023-12-01 → 2024-11-30¥1.3bn
—segment totaldepreciation2023-12-01 → 2024-11-30¥1.6bn
—segment totalrevenue2023-12-01 → 2024-11-30¥59.3bn
—segment totalrevenue external2023-12-01 → 2024-11-30¥58.0bn
—segment totalrevenue intersegment2023-12-01 → 2024-11-30¥1.4bn
—segment totalsegment profit2023-12-01 → 2024-11-30¥3.0bn
Total Of Reportable Segments And Otherssegment totaldepreciation2023-12-01 → 2024-11-30¥1.6bn
Total Of Reportable Segments And Otherssegment totalrevenue2023-12-01 → 2024-11-30¥59.4bn
Total Of Reportable Segments And Otherssegment totalrevenue external2023-12-01 → 2024-11-30¥58.0bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2023-12-01 → 2024-11-30¥1.4bn
Total Of Reportable Segments And Otherssegment totalsegment profit2023-12-01 → 2024-11-30¥2.8bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 1,935
ItemContextValueUnit
Net cash provided by used in financing activities (5-year summary)Prior3YearDuration-1093000000JPY
Net cash provided by used in financing activities (5-year summary)Prior2YearDuration1077000000JPY
Net cash provided by used in financing activities (5-year summary)Prior1YearDuration-2651000000JPY
Net cash provided by used in financing activities (5-year summary)CurrentYearDuration6202000000JPY
Cash and cash equivalents (5-year summary)Prior4YearInstant10807000000JPY
Cash and cash equivalents (5-year summary)Prior3YearInstant6803000000JPY
Cash and cash equivalents (5-year summary)Prior2YearInstant6758000000JPY
Cash and cash equivalents (5-year summary)Prior1YearInstant5978000000JPY
Cash and cash equivalents (5-year summary)CurrentYearInstant10067000000JPY
Number of employeesPrior4YearInstant1368
Number of employeesPrior3YearInstant1383
Number of employeesPrior2YearInstant1404
Number of employeesPrior1YearInstant1420
Number of employeesCurrentYearInstant1543
Average number of temporary workersPrior4YearInstant178
Average number of temporary workersPrior3YearInstant195
Average number of temporary workersPrior2YearInstant186
Average number of temporary workersPrior1YearInstant186
Average number of temporary workersCurrentYearInstant197
Net sales (5-year summary)Prior4YearDuration_NonConsolidatedMember23047000000JPY
Net sales (5-year summary)Prior3YearDuration_NonConsolidatedMember-JPY
Net sales (5-year summary)Prior2YearDuration_NonConsolidatedMember-JPY
Net sales (5-year summary)Prior1YearDuration_NonConsolidatedMember-JPY
Net sales (5-year summary)CurrentYearDuration_NonConsolidatedMember-JPY
Operating revenue1 (5-year summary)Prior4YearDuration_NonConsolidatedMember1303000000JPY
Operating revenue1 (5-year summary)Prior3YearDuration_NonConsolidatedMember2827000000JPY
Operating revenue1 (5-year summary)Prior2YearDuration_NonConsolidatedMember2770000000JPY
Operating revenue1 (5-year summary)Prior1YearDuration_NonConsolidatedMember2864000000JPY
Operating revenue1 (5-year summary)CurrentYearDuration_NonConsolidatedMember3787000000JPY
Ordinary income loss (5-year summary)Prior4YearDuration_NonConsolidatedMember304000000JPY
Ordinary income loss (5-year summary)Prior3YearDuration_NonConsolidatedMember290000000JPY
Ordinary income loss (5-year summary)Prior2YearDuration_NonConsolidatedMember209000000JPY
Ordinary income loss (5-year summary)Prior1YearDuration_NonConsolidatedMember-29000000JPY
Ordinary income loss (5-year summary)CurrentYearDuration_NonConsolidatedMember181000000JPY
Net income loss (5-year summary)Prior4YearDuration_NonConsolidatedMember788000000JPY
Net income loss (5-year summary)Prior3YearDuration_NonConsolidatedMember831000000JPY
Net income loss (5-year summary)Prior2YearDuration_NonConsolidatedMember702000000JPY
Net income loss (5-year summary)Prior1YearDuration_NonConsolidatedMember92000000JPY
Net income loss (5-year summary)CurrentYearDuration_NonConsolidatedMember294000000JPY
Capital stock (5-year summary)Prior4YearInstant_NonConsolidatedMember4528000000JPY
Capital stock (5-year summary)Prior3YearInstant_NonConsolidatedMember4557000000JPY
Capital stock (5-year summary)Prior2YearInstant_NonConsolidatedMember4581000000JPY
Capital stock (5-year summary)Prior1YearInstant_NonConsolidatedMember4605000000JPY
Capital stock (5-year summary)CurrentYearInstant_NonConsolidatedMember4629000000JPY
Total number of issued shares (5-year summary)Prior4YearInstant_NonConsolidatedMember40630087
Total number of issued shares (5-year summary)Prior3YearInstant_NonConsolidatedMember40772366
Total number of issued shares (5-year summary)Prior2YearInstant_NonConsolidatedMember40884504
Total number of issued shares (5-year summary)Prior1YearInstant_NonConsolidatedMember40982832
Total number of issued shares (5-year summary)CurrentYearInstant_NonConsolidatedMember41097566
Net assets (5-year summary)Prior4YearInstant_NonConsolidatedMember13976000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 24 of 24 passed
balance sheet identityconsolidated 2024-11-30pass
balance sheet identityconsolidated 2025-11-30pass rounding
balance sheet identitynon_consolidated 2024-11-30pass rounding
balance sheet identitynon_consolidated 2025-11-30pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2023-11-30pass
statement vs summary · net assetsconsolidated 2024-11-30pass
statement vs summary · net assetsconsolidated 2025-11-30pass
statement vs summary · net assetsnon_consolidated 2023-11-30pass
statement vs summary · net assetsnon_consolidated 2024-11-30pass
statement vs summary · net assetsnon_consolidated 2025-11-30pass
statement vs summary · net income attributable to parentconsolidated 2023-12-01/2024-11-30pass
statement vs summary · net income attributable to parentconsolidated 2024-12-01/2025-11-30pass
statement vs summary · operating cash flowconsolidated 2023-12-01/2024-11-30pass
statement vs summary · operating cash flowconsolidated 2024-12-01/2025-11-30pass
statement vs summary · revenueconsolidated 2023-12-01/2024-11-30pass
statement vs summary · revenueconsolidated 2024-12-01/2025-11-30pass
statement vs summary · revenuenon_consolidated 2023-12-01/2024-11-30pass
statement vs summary · revenuenon_consolidated 2024-12-01/2025-11-30pass
statement vs summary · total assetsconsolidated 2024-11-30pass
statement vs summary · total assetsconsolidated 2025-11-30pass
statement vs summary · total assetsnon_consolidated 2024-11-30pass
statement vs summary · total assetsnon_consolidated 2025-11-30pass